(Press Ganey Associates Inc.: South Bend, Indiana) -- By analyzing patient satisfaction data representing 1.5 million patients and 1,158 hospitals across the nation from January 2007 through June 2008, Press Ganey Associates Inc.

(AHRQ: Rockville, Maryland) -- The Patient Safety and Quality Improvement Act (Patient Safety Act) authorized the creation of patient safety organizations (PSOs) to improve safety through the collection and analysis of data on patient safety events.

(National Quality Forum: Washington, D.C.) -- To support consumer engagement and improved quality in health care, the National Quality Forum (NQF) endorsed guidelines for consumer-focused, internet-based public reporting.

(FDA: Rockville, Maryland) -- In a bid to extensively modernize the Food and Drug Administration’s (FDA’s) data management, data warehousing, information technology (IT) infrastructure, and IT security, FDA has awarded 10 contractors a total of $2.5 billion to implement the FDA’s Informatio

(FDA: Rockville, Maryland) -- Due to quality control problems at two Ranbaxy Laboratories Ltd. manufacturing plants in India, the U.S. Food and Drug Administration (FDA) issued two warning letters and an import alert for generic drugs produced by the company.

(Best Practices LLC: Chapel Hill, North Carolina) -- Within the hospital marketplace, pharmaceutical and biotechnology salespeople must negotiate increasingly complex organizational and decision-making structures to effectively represent their brands.

(Medco Health Solutions Inc.: Franklin Lakes, N.J.) -- Noting that the United States spends twice as much per capita on health care as most other developed nations, but achieves no better clinical outcomes, Medco Health Solutions Inc. chairman and CEO, David B.

(HHS: Washington, D.C.) -- The Chartered Value Exchanges (CVEs) is a growing movement to build a health care system where consumers, providers, and payers make decisions based on the value and quality of care.

(FDA: Dallas, Texas) -- The U.S. Food and Drug Administration (FDA) Dallas District, in cooperation with the Society of Clinical Research Associates (SoCRA), is holding a conference on FDA Clinical Trial Requirements Regulations, Compliance, and GCP.